INS and Insulin resistance: In animal models, TMAO has been shown to induce T2D via increasing fasting insulin levels and insulin resistance (HOMA-IR), aggravating impaired glucose tolerance [8,9], inducing adipose tissue inflammation, and obstructing the hepatic insulin signalling pathway [8].